Arbutus Biopharma Corp. (ABUS)
5.12
0.00 (0.00%)
USD |
NASDAQ |
Sep 11, 16:00
5.12
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Price : 5.12 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 5.17 | 5.175 | 5.11 | 5.12 | 1.850M |
| Sep 10, 2026 | 5.11 | 5.165 | 5.10 | 5.12 | 2.450M |
| Sep 09, 2026 | 5.16 | 5.23 | 5.125 | 5.17 | 5.507M |
| Sep 08, 2026 | 5.10 | 5.20 | 5.08 | 5.18 | 5.291M |
| Sep 04, 2026 | 5.09 | 5.17 | 5.09 | 5.15 | 5.198M |
| Sep 03, 2026 | 5.11 | 5.154 | 5.095 | 5.12 | 3.227M |
| Sep 02, 2026 | 5.10 | 5.19 | 5.09 | 5.10 | 2.976M |
| Sep 01, 2026 | 5.05 | 5.10 | 5.05 | 5.09 | 2.610M |
| Aug 31, 2026 | 5.05 | 5.105 | 4.992 | 5.08 | 3.562M |
| Aug 28, 2026 | 5.15 | 5.19 | 5.05 | 5.07 | 4.769M |
| Aug 27, 2026 | 5.16 | 5.215 | 5.14 | 5.17 | 3.580M |
| Aug 26, 2026 | 5.19 | 5.23 | 5.175 | 5.19 | 4.597M |
| Aug 25, 2026 | 5.25 | 5.26 | 5.13 | 5.20 | 8.913M |
| Aug 24, 2026 | 5.18 | 5.28 | 5.170 | 5.20 | 18.14M |
| Aug 21, 2026 | 5.20 | 5.45 | 5.09 | 5.21 | 18.07M |
| Aug 20, 2026 | 4.92 | 4.96 | 4.74 | 4.77 | 1.274M |
| Aug 19, 2026 | 4.83 | 5.18 | 4.83 | 4.98 | 3.428M |
| Aug 18, 2026 | 4.79 | 4.85 | 4.645 | 4.84 | 1.446M |
| Aug 17, 2026 | 4.66 | 4.795 | 4.630 | 4.71 | 1.388M |
| Aug 14, 2026 | 4.60 | 4.71 | 4.55 | 4.67 | 1.439M |
| Aug 13, 2026 | 4.56 | 4.65 | 4.505 | 4.58 | 1.390M |
| Aug 12, 2026 | 4.59 | 4.635 | 4.42 | 4.59 | 1.399M |
| Aug 11, 2026 | 4.60 | 4.72 | 4.60 | 4.67 | 1.048M |
| Aug 10, 2026 | 4.59 | 4.665 | 4.545 | 4.59 | 969216.0 |
| Aug 07, 2026 | 4.57 | 4.65 | 4.53 | 4.63 | 796105.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Moderna, Inc. | 143.97 |
| Insmed, Inc. | 129.41 |
| Pfizer Inc. | 27.72 |
| Gossamer Bio, Inc. | 10.73 |
| Legend Biotech Corp. | 18.64 |
Price Related Metrics
| PE Ratio | 6.536 |
| PS Ratio | 5.473 |
| Price to Book Value | 3.911 |
| Earnings Yield | 15.30% |
| Market Cap | 1.012B |
| Operating PE Ratio | 6.746 |
| Normalized PE Ratio | 6.584 |